QDEL (QuidelOrtho) שווי פירמה כולל

QuidelOrtho (QDEL) generates revenue through the development and sale of rapid pathology detection kits, including molecular and enzyme-linked immunosorbent assay systems. The company's current strategy relies on the stable laboratory equipment segment and the implementation of new diagnostic panels. The market capitalization trend on GURU.Markets, which stands at 3896.28, complements data regarding the release of robotic conveyors and analyzers that minimize human error in biochemical research.

Enterprise value aggregates market capitalization and net debt, determining the total cost to acquire all assets while accounting for credit obligations. An analysis of the total capital valuation metric for QuidelOrtho (QDEL) allows for a comparison between the value of innovations in portable diagnostics and the debt load, confirming the financial stability of this rapid testing leader as it scales its business.